Study objectives: Severe acute respiratory syndrome (SARS) is a rapidly progressive
disease caused by a novel coronavirus (CoV) infection. However, the disease presentation …

Background. Previous studies have shown that common human coronavirus might be
neurotropic, although it was first isolated as a pathogen of the respiratory tract. We noticed …

Background: Severe acute respiratory syndrome (SARS) is a newly discovered disease
caused by a novel coronavirus. The present study studied the longitudinal profile of …

A seroepidemiologic study was conducted in North China in 2003 to determine the
neutralizing antibody titer of severe acute respiratory syndrome (SARS) convalescent sera …

Background: The etiologic agent of severe acute respiratory syndrome (SARS) is a recently
identified, positive single-stranded RNA (ssRNA) coronavirus (SARS-CoV). Little is known …

This article describes the pathological studies of fatal severe acute respiratory syndrome
(SARS) in a 73-year-old man during an outbreak of SARS in Taiwan, 2003. Eight days …

Current treatment schemes for severe acute respiratory syndrome (SARS) include broad-
spectrum antibiotics, glucocorticoids, and ribavirin. We evaluated the susceptibility of the …

Background: Severe acute respiratory syndrome (SARS) has become a global public health
emergency. Objective: To evaluate the characteristics and outcomes of patients with SARS …

ABSTRACT Serum levels of IgG, IgM and IgA against severe acute respiratory distress
syndrome (SARS)-associated coronavirus (SARS-CoV) were detected serially with the use …

Severe acute respiratory syndrome (SARS), a new disease with symptoms similar to those of
atypical pneumonia, raised a global alert in March 2003. Because of its relatively high …